Ro-25-1132

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRo-25-1132
Drug Alias NameRo-25-1132
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial DNA gyrase inhibitors
TargetsBacterial DNA gyrase
Therapy Area/IndicationsMycosesBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Clinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsMycosesBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A